Evid Based Spine Care J 2013; 04(01): 054-058
DOI: 10.1055/s-0033-1341597
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Thoracic Spinal Metastasis of Merkel Cell Carcinoma in an Immunocompromised Patient: Case Report

Authors

  • Nicholas A. Madden

    1   School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, United States
  • Patricia A. Thomas

    2   Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Philip L. Johnson

    3   Department of Radiology, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Karen K. Anderson

    4   Department of Neurosurgery, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Paul M. Arnold

    4   Department of Neurosurgery, University of Kansas Medical Center, Kansas City, Kansas, United States
Further Information

Publication History

24 September 2012

28 November 2012

Publication Date:
01 May 2013 (online)

Abstract

Study Design Case report.

Objective Merkel cell carcinoma (MCC), an uncommon cutaneous neuroendocrine malignancy, is a rare cause of spinal metastasis, with only five cases previously reported. We report a rare case of MCC metastatic to the spine in an immunocompromised patient.

Methods A 55-year-old male with previously resected MCC, immunocompromised due to cardiac transplant, presented with sharp mid-thoracic back pain radiating around the trunk to the midline. Computed tomography of the thoracic spine showed a dorsal epidural mass from T6 to T8 with compression of the spinal cord. Laminectomy and subtotal tumor resection were performed, and pathology confirmed Merkel cell tumor through immunohistochemistry staining positive for cytokeratin 20 and negative for thyroid transcription factor-1.

Results Further treatment with radiation therapy was initiated, and the patient did well for 4 months after surgery, but returned with a lesion in the cervical spine. He then opted for hospice care.

Conclusions With an increasing number of immunocompromised patients presenting with back pain, MCC should be considered in the differential diagnosis of spinal metastatic disease.